Daniel S. Jonas - 28 Apr 2023 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Special Counsel & Corp Secy
Signature
Daniel S. Jonas
Issuer symbol
CNMD
Transactions as of
28 Apr 2023
Net transactions value
-$284,143
Form type
4
Filing time
02 May 2023, 16:19:48 UTC
Previous filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Gift $0 -626 -4.4% $0.000000 13,462 28 Apr 2023 Direct
transaction CNMD Common Stock Options Exercise $976,900 +10,000 +74% $97.69 23,462 28 Apr 2023 Direct
transaction CNMD Common Stock Sale $690,635 -5,500 -23% $125.57 17,962 28 Apr 2023 Direct F1
transaction CNMD Common Stock Sale $544,896 -4,300 -24% $126.72 13,662 28 Apr 2023 Direct F2
transaction CNMD Common Stock Sale $25,512 -200 -1.5% $127.56 13,462 28 Apr 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -10,000 -50% $0.000000 10,000 28 Apr 2023 Common Stock 10,000 $97.69 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.30 to $126.25. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.36 to $127.26. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder,
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.42 to $127.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period